Industry NewsCobra Biologics selected to manufacture plasmids for Phase I clinical trial of Scancell’s COVID-19 vaccine in 2021
Product NewsCobra Biologics completes production of master cell banks for CombiGene’s epilepsy gene therapy drug candidate
Industry NewsCobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Industry NewsCobra Biologics and Centre for Process Innovation Announce Collaboration to Advance Development of Regenerative Medicines
Industry NewsCobra Biologics and The University of Manchester Announce Collaboration to Improve Industrial Scale-up of Mammalian Cell Bioprocessing
Product NewsCobra Biologics and Recopharma Enter agreement to utilise Cobra’s Cell Line Development Service- MaxXpress
